Samso News unpacks the Identifai Genetics IPO (ASX: ID1), which seeks A$10 million at 20 cents to take its non-invasive prenatal test into a US study.

Australian small caps continued to outperform on Wednesday, with the S&P/ASX Small Ordinaries gaining for the session and extending its five-day advance to 1.48%, while the broader market finished only marginally higher.

Stavely Minerals looks like it is recovering. It is higher than six months ago and above its 200-day moving average. This Chart Read tests that impression against the trend measures, then goes through the twelve biggest one-day moves of the year. Seven had no ASX announcement behind them, the biggest was reversed the next day, and one 18.7 per cent rise took A$1,236 of turnover.

Australian shares finished Tuesday higher as technology stocks recovered alongside Wall Street’s artificial intelligence rally, smaller companies outperformed and a proposed $333 million takeover of Global Lithium Resources drew attention to the lithium sector.

Samso News reviews the Overwatch Technologies (ASX: OWL) IPO. A$8 million at 20 cents, a licensed sensing core from a related party, A$1.88 million received but no revenue recognised, and a 38.8 per cent free float.

Australian shares finished virtually unchanged on Monday as gains across the major banks offset weakness in technology, resources and smaller companies.

Australian shares finished a volatile week slightly lower, with oil prices, rising bond yields and interest-rate expectations weighing on the broader market. Beneath the headline indices, however, smaller companies and gold producers recorded stronger performances.

Australian shares posted a second consecutive gain on Thursday, although a strong opening rally faded as investors weighed the prospect of further interest-rate increases.

OD6 Metals has remapped Mammoth at its Quinn Fluorspar Project in Nevada, growing the interpreted target past 14,000 square metres. What the channel results settle.

Australian shares regained some ground on Wednesday, but the recovery now faces an overnight test from US consumer spending figures, inflation indicators and the Federal Reserve’s interest-rate decision.